Jeffrey A. Whitnell

Filings by Jeffrey A. Whitnell span 2 companies, the busiest being Akorn Inc and Elite Pharmaceuticals Inc. The record holds 24 filings, for trades running from 31 March 2006 to 22 November 2023.

The open-market side counts 1 purchase for €9,870 alongside 6 sales for €73k. On balance, insiders were net sellers of €63k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 17 share grants.

The newest entry dates from 27 November 2023: a share grant of €18k, in Elite Pharmaceuticals Inc. The last insider purchase was made public on 16 March 2011, 5,701 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.